The U.S. and EU support is a ‘signal that IP rights can legitimately be limited’ during a health crisis like COVID-19, one expert said.
U.S. backs waiver on vaccine patents. What it means and what Canada thinks
© The Crystal Eyes
The U.S. and EU support is a ‘signal that IP rights can legitimately be limited’ during a health crisis like COVID-19, one expert said.
© The Crystal Eyes